Teresa Mezza

2.6k total citations
74 papers, 1.8k citations indexed

About

Teresa Mezza is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Teresa Mezza has authored 74 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Surgery, 35 papers in Endocrinology, Diabetes and Metabolism and 23 papers in Molecular Biology. Recurrent topics in Teresa Mezza's work include Pancreatic function and diabetes (28 papers), Metabolism, Diabetes, and Cancer (17 papers) and Diabetes and associated disorders (16 papers). Teresa Mezza is often cited by papers focused on Pancreatic function and diabetes (28 papers), Metabolism, Diabetes, and Cancer (17 papers) and Diabetes and associated disorders (16 papers). Teresa Mezza collaborates with scholars based in Italy, United States and Denmark. Teresa Mezza's co-authors include Andrea Giaccari, Alfredo Pontecorvi, Gian Pio Sorice, Giovanna Muscogiuri, Francesca Cinti, C. Cefalo, Rohit Kulkarni, Simona Moffa, Annamaria Prioletta and Flavia Impronta and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Teresa Mezza

70 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teresa Mezza Italy 24 758 694 428 362 325 74 1.8k
Gian Pio Sorice Italy 22 683 0.9× 520 0.7× 399 0.9× 337 0.9× 219 0.7× 47 1.7k
Hanne L. Gulseth Norway 17 636 0.8× 420 0.6× 354 0.8× 175 0.5× 93 0.3× 31 1.4k
Tamaki Sasaki Japan 27 441 0.6× 409 0.6× 580 1.4× 235 0.6× 192 0.6× 84 2.2k
Yong‐Ki Min South Korea 25 955 1.3× 677 1.0× 449 1.0× 144 0.4× 208 0.6× 101 2.0k
Laura Schreier Argentina 27 743 1.0× 438 0.6× 233 0.5× 234 0.6× 118 0.4× 115 1.9k
Ohk‐Hyun Ryu South Korea 19 468 0.6× 256 0.4× 288 0.7× 239 0.7× 96 0.3× 50 1.5k
Marisa Passarelli Brazil 27 697 0.9× 483 0.7× 469 1.1× 92 0.3× 97 0.3× 105 1.8k
Federica Barutta Italy 25 632 0.8× 403 0.6× 741 1.7× 174 0.5× 177 0.5× 59 2.4k
Manuel Macías‐González Spain 26 300 0.4× 276 0.4× 765 1.8× 312 0.9× 150 0.5× 78 1.9k
Xulei Tang China 21 445 0.6× 237 0.3× 689 1.6× 430 1.2× 89 0.3× 85 1.8k

Countries citing papers authored by Teresa Mezza

Since Specialization
Citations

This map shows the geographic impact of Teresa Mezza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresa Mezza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresa Mezza more than expected).

Fields of papers citing papers by Teresa Mezza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teresa Mezza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresa Mezza. The network helps show where Teresa Mezza may publish in the future.

Co-authorship network of co-authors of Teresa Mezza

This figure shows the co-authorship network connecting the top 25 collaborators of Teresa Mezza. A scholar is included among the top collaborators of Teresa Mezza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teresa Mezza. Teresa Mezza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giuseppe, Gianfranco Di, et al.. (2025). The multifaceted role of agents counteracting metabolic syndrome: A new hope for gastrointestinal cancer therapy. Pharmacology & Therapeutics. 270. 108847–108847.
2.
Giuseppe, Gianfranco Di, Giuseppe Quero, Enrico Celestino Nista, et al.. (2025). Incretin system and glucagon secretion in patients with chronic pancreatitis. European Journal of Clinical Investigation. 55(12). e70093–e70093.
3.
Giuseppe, Gianfranco Di, Giuseppe Quero, Francesca Cinti, et al.. (2025). Altered GIP/GLP-1 Secretion Ratio is Associated With Impaired β Cell Function in Humans. The Journal of Clinical Endocrinology & Metabolism. 111(1). e240–e246. 2 indexed citations
4.
Fiorillo, Claudio, Teresa Mezza, Roberta Menghi, et al.. (2025). Surgical treatment of synchronous liver-only oligometastatic pancreatic adenocarcinoma: a systematic review and meta-analysis of long-term outcomes. International Journal of Surgery. 111(5). 3589–3598.
5.
Ciardullo, Stefano, Mario Luca Morieri, Teresa Vanessa Fiorentino, et al.. (2024). GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes. Acta Diabetologica. 61(8). 941–950. 9 indexed citations
6.
Wong, Kuan Yau, Alexandra Müller, Sahar Keshvari, et al.. (2024). Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis. Nature Communications. 15(1). 4527–4527. 9 indexed citations
7.
Giuseppe, Gianfranco Di, et al.. (2024). The influence of insulin and incretin-based therapies on renal tubular transport. Journal of Nephrology. 37(8). 2139–2150. 1 indexed citations
8.
Giuseppe, Gianfranco Di, Pietro Manuel Ferraro, Giuseppe Quero, et al.. (2024). Reduced incretin effect precedes diabetes development following duodenopancreatectomy in individuals without diabetes. Journal of Clinical Investigation. 134(8). 5 indexed citations
9.
Moffa, Simona, Gian Pio Sorice, Gianfranco Di Giuseppe, et al.. (2024). A single bout of physical exercise improves 1-hour post-load plasma glucose in healthy young adults. Journal of Endocrinological Investigation. 48(2). 455–464. 2 indexed citations
10.
Capece, Umberto, Chiara Pavanello, Francesca Cinti, et al.. (2023). Dapagliflozin-Induced Myocardial Flow Reserve Improvement is not Associated with HDL Ability to Stimulate Endothelial Nitric Oxide Production. Diabetes Therapy. 15(1). 257–268. 6 indexed citations
11.
Moffa, Simona, Teresa Mezza, Pietro Manuel Ferraro, et al.. (2023). Effects of PCSK9 inhibition on glucose metabolism and β-cell function in humans: a pilot study. Frontiers in Endocrinology. 14. 1124116–1124116. 1 indexed citations
12.
Bianchetti, Giada, C. Cefalo, Carla Ferreri, et al.. (2023). Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes. European Journal of Clinical Investigation. 54(3). e14121–e14121. 12 indexed citations
13.
Jiménez‐Sánchez, Cecilia, Flore Sinturel, Teresa Mezza, et al.. (2023). Lysophosphatidylinositols Are Upregulated After Human β-Cell Loss and Potentiate Insulin Release. Diabetes. 73(1). 93–107. 4 indexed citations
14.
Severino, Andrea, Teresa Mezza, Antonio Gasbarrini, et al.. (2023). Antibiotic Utilization in Acute Pancreatitis: A Narrative Review. Antibiotics. 12(7). 1120–1120. 9 indexed citations
15.
Jiménez‐Sánchez, Cecilia, Teresa Mezza, Flore Sinturel, et al.. (2022). Circulating 1,5-Anhydroglucitol as a Biomarker of ß-cell Mass Independent of a Diabetes Phenotype in Human Subjects. The Journal of Clinical Endocrinology & Metabolism. 107(10). 2833–2843. 11 indexed citations
16.
Brusco, Noemi, Guido Sebastiani, Gianfranco Di Giuseppe, et al.. (2022). Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes. Diabetologia. 66(2). 354–366. 27 indexed citations
17.
Mezza, Teresa, Pietro Manuel Ferraro, Gianfranco Di Giuseppe, et al.. (2021). Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes. Journal of Clinical Investigation. 131(12). 26 indexed citations
18.
Sorice, Gian Pio, Francesca Cinti, Lucia Leccisotti, et al.. (2021). Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion: Rationale and Design of The DAPAHEART Trial. Diabetes Therapy. 12(7). 2101–2113. 8 indexed citations
19.
Cefalo, C., Francesca Cinti, Simona Moffa, et al.. (2019). Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives. Cardiovascular Diabetology. 18(1). 20–20. 130 indexed citations
20.
Sorice, Gian Pio, et al.. (2012). Metabolic syndrome in transplant patients: an updating point of view.. PubMed. 37(3). 211–20. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gian Pio Sorice Breakdown of academic impact, for papers by Hanne L. Gulseth Breakdown of academic impact, for papers by Tamaki Sasaki Breakdown of academic impact, for papers by Yong‐Ki Min Breakdown of academic impact, for papers by Laura Schreier Breakdown of academic impact, for papers by Ohk‐Hyun Ryu Breakdown of academic impact, for papers by Marisa Passarelli Breakdown of academic impact, for papers by Federica Barutta Breakdown of academic impact, for papers by Manuel Macías‐González Breakdown of academic impact, for papers by Xulei Tang
Rankless by CCL
2026